539680
GANGAPHARM
Start SIP
Invest Now
Start SIP in GANGAPHARM
Performance
- Low
- ₹12
- High
- ₹12
- 52 Week Low
- ₹9
- 52 Week High
- ₹15
- Open Price₹12
- Previous Close₹12
- Volume8,000
- 50 DMA₹15.32
- 100 DMA₹14.98
- 200 DMA₹12.13
Investment Returns
- Over 1 Month + 2.74%
- Over 3 Month -17.81%
- Over 6 Month -17.81%
- Over 1 Year -29.41%
Smart Investing Starts Here Start SIP with Ganga Pharmaceuticals for Steady Growth!
Ganga Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 89.8
- PEG Ratio
- -
- Market Cap Cr
- 7
- P/B Ratio
- 0.9
- Average True Range
- 1.66
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -1.5
- RSI
- 43.45
- MFI
- 56.27
Ganga Pharmaceuticals Financials
Ganga Pharmaceuticals Technicals
EMA & SMA
Current Price
₹12.00
0
(0%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹13.53
- 50 Day
- ₹15.32
- 100 Day
- ₹14.98
- 200 Day
- ₹12.13
Resistance and Support
12
- R3 12.00
- R2 12.00
- R1 12.00
- S1 12.00
- S2 12.00
- S3 12.00
Ganga Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-07 | Half Yearly Results | |
| 2025-05-20 | Audited Results | |
| 2024-11-08 | Half Yearly Results | |
| 2024-05-16 | Audited Results | |
| 2023-12-04 | Preferential issue of shares |
Ganga Pharmaceuticals F&O
About Ganga Pharmaceuticals
- NSE Symbol
- GANGAPHARM
- BSE Symbol
- 539680
- Managing Director & CEO
- Mr. Bharat Brijmohan Sharma
- ISIN
- INE615T01017
Similar Stocks to Ganga Pharmaceuticals
Ganga Pharmaceuticals FAQs
Ganga Pharmaceuticals share price is ₹12 As on 15 February, 2026 | 06:18
The Market Cap of Ganga Pharmaceuticals is ₹7.1 Cr As on 15 February, 2026 | 06:18
The P/E ratio of Ganga Pharmaceuticals is 89.8 As on 15 February, 2026 | 06:18
The PB ratio of Ganga Pharmaceuticals is 0.9 As on 15 February, 2026 | 06:18
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.